140 related articles for article (PubMed ID: 15246161)
1. Prostate apoptosis response gene-4 (par-4) abrogates the survival function of p185(BCR-ABL) in hematopoietic cells.
Kukoc-Zivojnov N; Puccetti E; Chow KU; Bergmann M; Ruthardt M; Hoelzer D; Mitrou PS; Weidmann E; Boehrer S
Exp Hematol; 2004 Jul; 32(7):649-56. PubMed ID: 15246161
[TBL] [Abstract][Full Text] [Related]
2. BCR-ABL and constitutively active erythropoietin receptor (cEpoR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell line.
Ahmed M; Dusanter-Fourt I; Bernard M; Mayeux P; Hawley RG; Bennardo T; Novault S; Bonnet ML; Gisselbrecht S; Varet B; Turhan AG
Oncogene; 1998 Jan; 16(4):489-96. PubMed ID: 9484838
[TBL] [Abstract][Full Text] [Related]
3. Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells.
Hoover RR; Gerlach MJ; Koh EY; Daley GQ
Oncogene; 2001 Sep; 20(41):5826-35. PubMed ID: 11593388
[TBL] [Abstract][Full Text] [Related]
4. In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors.
Brieger A; Boehrer S; Schaaf S; Nowak D; Ruthardt M; Kim SZ; Atadja P; Hoelzer D; Mitrou PS; Weidmann E; Chow KU
Biochem Pharmacol; 2004 Jul; 68(1):85-93. PubMed ID: 15183120
[TBL] [Abstract][Full Text] [Related]
5. BCR-ABL activates pathways mediating cytokine independence and protection against apoptosis in murine hematopoietic cells in a dose-dependent manner.
Cambier N; Chopra R; Strasser A; Metcalf D; Elefanty AG
Oncogene; 1998 Jan; 16(3):335-48. PubMed ID: 9467959
[TBL] [Abstract][Full Text] [Related]
6. Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis.
Wang Z; Sampath J; Fukuda S; Pelus LM
Cancer Res; 2005 Sep; 65(18):8224-32. PubMed ID: 16166298
[TBL] [Abstract][Full Text] [Related]
7. Role of p21(WAF1/CIP1) as an attenuator of both proliferative and drug-induced apoptotic signals in BCR-ABL-transformed hematopoietic cells.
Forster K; Obermeier A; Mitina O; Simon N; Warmuth M; Krause G; Hallek M
Ann Hematol; 2008 Mar; 87(3):183-93. PubMed ID: 17960378
[TBL] [Abstract][Full Text] [Related]
8. Bcr: a negative regulator of the Bcr-Abl oncoprotein.
Wu Y; Ma G; Lu D; Lin F; Xu HJ; Liu J; Arlinghaus RB
Oncogene; 1999 Aug; 18(31):4416-24. PubMed ID: 10442632
[TBL] [Abstract][Full Text] [Related]
9. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells.
Rizzo MT; Regazzi E; Garau D; Akard L; Dugan M; Boswell HS; Rizzoli V; Carlo-Stella C
Cancer Res; 1999 Oct; 59(19):5047-53. PubMed ID: 10519422
[TBL] [Abstract][Full Text] [Related]
11. Effect of mutational inactivation of tyrosine kinase activity on BCR/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitors.
Ramaraj P; Singh H; Niu N; Chu S; Holtz M; Yee JK; Bhatia R
Cancer Res; 2004 Aug; 64(15):5322-31. PubMed ID: 15289338
[TBL] [Abstract][Full Text] [Related]
12. Bcr - Abl-mediated resistance to apoptosis is independent of PI 3-kinase activity.
Amarante-Mendes GP; Jascur T; Nishioka WK; Mustelin T; Green DR
Cell Death Differ; 1997 Oct; 4(7):548-54. PubMed ID: 14555967
[TBL] [Abstract][Full Text] [Related]
13. ABL oncogenes directly stimulate two distinct target cells in bone marrow from 5-fluorouracil-treated mice.
Kelliher MA; Weckstein DJ; Knott AG; Wortis HH; Rosenberg N
Oncogene; 1993 May; 8(5):1249-56. PubMed ID: 8479746
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
Kurosu T; Ohki M; Wu N; Kagechika H; Miura O
Cancer Res; 2009 May; 69(9):3927-36. PubMed ID: 19366808
[TBL] [Abstract][Full Text] [Related]
15. The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway.
Cortez D; Stoica G; Pierce JH; Pendergast AM
Oncogene; 1996 Dec; 13(12):2589-94. PubMed ID: 9000132
[TBL] [Abstract][Full Text] [Related]
16. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
Kometani K; Aoki M; Kawamata S; Shinozuka Y; Era T; Taniwaki M; Hattori M; Minato N
Cancer Res; 2006 Oct; 66(20):9967-76. PubMed ID: 17047059
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic characterization of a BCR-ABL transduced mouse cell line.
Rudolph C; Hegazy AN; von Neuhoff N; Steinemann D; Schröck E; Stripecke R; Klein C; Schlegelberger B
Cancer Genet Cytogenet; 2005 Aug; 161(1):51-6. PubMed ID: 16080957
[TBL] [Abstract][Full Text] [Related]
18. Critical role for cyclin D2 in BCR/ABL-induced proliferation of hematopoietic cells.
Jena N; Deng M; Sicinska E; Sicinski P; Daley GQ
Cancer Res; 2002 Jan; 62(2):535-41. PubMed ID: 11809706
[TBL] [Abstract][Full Text] [Related]
19. Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance.
Underhill-Day N; Pierce A; Thompson SE; Xenaki D; Whetton AD; Owen-Lynch PJ
Br J Haematol; 2006 Mar; 132(6):774-83. PubMed ID: 16487179
[TBL] [Abstract][Full Text] [Related]
20. Ectopic expression of Par-4 leads to induction of apoptosis in CNS tumor cell lines.
Vetterkind S; Boosen M; Scheidtmann KH; Preuss U
Int J Oncol; 2005 Jan; 26(1):159-67. PubMed ID: 15586236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
